THE FREQUENCY AND DISTRIBUTION OF HUMAN PAPILLOMAVIRUS TYPES IN THE MALE POPULATION

Maja Crnogorac

doi:10.5937/mp75-51852

Maja Crnogorac Univerzitet u Beogradu, Medicinski fakultet

DOI: https://doi.org/10.5937/mp75-51852

Keywords: Human papillomavirus, genotyping, men, genital infections

Abstract

Introduction: One of the leading causes of sexually transmitted infections is human papillomavirus (HPV). Depending on the population, the anatomical location of sampling, and the techniques utilized for detection and typing, genital HPV infections can be identified in 16% to 69% of cases in healthy men.

The Aim: This research aimed to determine the frequency and distribution of HPV types in the genital tract of men using molecular methods in four cities in the Republic of Serbia.

Material and methods: This retrospective study included 468 men with suspected genital HPV infection from Belgrade, Kragujevac, Niš, and Novi Sad. The data were collected in the period from 2017 to 2021. Detection and genotyping of the virus was done using the Real-Time PCR method and Sanger DNA sequencing. Descriptive statistics and the χ² test were used in the statistical significance testing.

Results: The presence of HPV was proven in 77 out of 468 samples (16%). The highest HPV prevalence of 35.2% was detected in men older than 45 years of age. The percentage of positive samples was highest in men from Niš (24%), followed by Kragujevac (22.1%), Belgrade (20%), and Novi Sad (11.6%). The difference in HPV positivity in men between cities was found to be statistically significant (p=0.02). A total of 16 different HPV types were detected. HPV 16 is the most frequently detected genotype (30%), followed by HPV 31 (14%), HPV 52 (14%), while types 56, 11, 33, 39 and 45 were identified with lower frequency. HPV 16 was the most often found type in all cities, except for Kragujevac, where HPV 52, 56, and 59 were the most frequently identified.

Conclusion: The results show the presence of 16 different genital HPV genotypes in men with the highest frequency of HPV 16. HPV infection was detected in 16% of cases, where the highest prevalence was observed in older men.

References

1. Van Doorslaer K, Bernard HU, Chen Z, de Villiers EM, zur Hausen H, Burk RD. Papillomaviruses: evolution, Linnaean taxonomy and current nomenclature. Trends Microbiol. 2011;19(2):49-50.
2. Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst. 2010;102(5):325-39.
3. Jiang L, Tian X, Peng D, Zhang L, Xie F, et al. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory. PLoS One. 2019;14.
4. Nielson CM, Flores R, Harris RB, Abrahamsen M, Papenfuss MR, Dunne EF, et al. Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1107-14.
5. Sichero L, Giuliano AR, Villa LL. Human Papillomavirus and Genital Disease in Men: What We Have Learned from the HIM Study. Acta Cytol. 2019;63(2):109-117.
6. Davarmanesh M, Jazayeri SM, Dezfulian M, Gharavi MJ. High risk genotype distribution of human papillomavirus (HPV) according to age groups in Iranian asymptomatic men. Infect Agent Cancer. 2020;15:29.
7. Aguilar LV, Lazcano-Ponce E, Vaccarella S, Cruz A, Hernández P, Smith JS, et al. Human papillomavirus in men: comparison of different genital sites. Sex Transm Infect. 2006;82(1):31-3.
8. Colón-López V, Ortiz AP, Palefsky J. Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men. P R Health Sci J. 2010;29(3):232-40.
9. Lajous M, Mueller N, Cruz-Valdéz A, Aguilar LV, Franceschi S, Hernández-Avila M, et al. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev. 2005;14(7):1710-6.
10. Alemany L, Cubilla A, Halec G, Kasamatsu E, Quirós B, Masferrer E, et al. Role of Human Papillomavirus in Penile Carcinomas Worldwide. Eur Urol. 2016;69(5):953-61.
11. Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Kornegay JR, et al. Human papillomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis. 2003;187(7):1064-70.
12. Hebnes JB, Olesen TB, Duun-Henriksen AK, Munk C, Norrild B, Kjaer SK. Prevalence of genital human papillomavirus among men in Europe: systematic review and meta-analysis. J Sex Med. 2014;11(11):2630-44.
13. Castellsagué X, Bosch FX, Muñoz N, Meijer CJ, Shah KV, de Sanjose S, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med. 2002;346(15):1105-12.